Kamau Therapeutics

San Francisco, CA · Founded 2023 · Privately Held (backing)

Operator of a clinical-stage, next-generation gene correction company intended to cure serious and life-threatening diseases. Kamau Therapeutics is based in San Francisco, CA and was founded in 2023. It was valued at $48.5 million at its seed round in Jun 2025, the last priced event on record. It has raised $31.8 million across 1 recorded round; the latest was a $5 million seed round in May 2025.

PMV mark · valuation
$48.5M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$31.8M
Last round
Seed Round
May 2025
How much has Kamau Therapeutics raised?
$31.8Macross 1 recorded rounds · May 2025 – May 2025

Most recently, Kamau Therapeutics raised $5.0M in its Seed Round (May 2025).

Free account
More of Kamau Therapeutics with a free account
  • ·Watch Kamau Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kamau Therapeutics round by round

1 rounds
May 2025Seed Round$5.0MSEC filing▮
6 investors participated

How much has Kamau Therapeutics raised?

Kamau Therapeutics has raised $31.8 million in total; 1 of its rounds is on record. The largest on record was a $5 million seed round in May 2025.

Kamau Therapeutics has filed 1 Form D with the SEC, most recently in Jun 2025 ($5 million sold to 6 investors).

Kamau Therapeutics investors

3 investors are on record for Kamau Therapeutics, including Draper Associates, Modi Ventures and NEVA SGR. By type, the record holds 3 venture capital firms. The seed round in May 2025 drew 6 investors.

For fundraisers
Raising for a company like Kamau Therapeutics?

3 investors have backed Kamau Therapeutics.

See all 3 investors →

Frequently asked about Kamau Therapeutics

How much has Kamau Therapeutics raised?
Kamau Therapeutics has raised $31.8M in total across 1 recorded funding rounds.
When was Kamau Therapeutics's last funding round?
Kamau Therapeutics's most recent recorded round was Seed Round in May 2025, raising $5.0M.